US Patent Issued to Aptarion Biotech on July 15 for "CXCL8 binding nucleic acids" (German Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,206, issued on July 15, was assigned to Aptarion Biotech AG (Berlin).

"CXCL8 binding nucleic acids" was invented by Kai Hohlig (Berlin), Axel Vater (Berlin), Werner Purschke (Berlin), Dirk Zboralski (Berlin) and Christian Maasch (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to an L-nucleic acid molecule capable of binding to human CXCL8, wherein the L-nucleic acid molecule comprises a central stretch of nucleotides, wherein the central stretch of nucleotides comprises a nucleotide sequence of 5'-GG A AGU ACGUGGA AAGCCRA(Xu)RAGUGUGUCCCG-3'[SEQ. ID. NO: 27], wherein Xu is U or absent."

The patent was filed on...